Sanofi Seeks Chinese Partners For R&D Work
This article was originally published in PharmAsia News
Executive Summary
Sanofi Aventis seeks to involve Chinese universities and laboratories in research partnerships by the end of this year, concentrating on cancer and rheumatoid arthritis treatments. The head of Sanofi's research and development said the company hopes the joint efforts with six Chinese institutions would help it discover new drugs. Marc Cluzel notes the Chinese government is investing in biological research and education he believes will make China a key resource for innovative new drugs by 2015. The Sanofi approach differs from other drug makers who plan to build R&D facilities in China. (Click here for more - a subscription may be required